Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Viracta Therapeutics
3160
Viracta Therapeutics
Technology
Biotechnology
Health Care
Medical
Therapeutics
Viracta is advancing medicines based on its viral gene activation therapy approach to benefit patients with viral-associated cancers & other serious diseases.
Suggest edits
Raised
$18.4M
Follow us
Also headquartered in San Diego
Qualcomm
Intuit
Dan
GoFundMe
Industry
Edge
Illumina
Bandsintown
TuSimple
San Diego Comic-Con
Companies in the same industry
Stemirna Therapeutics
DTx Pharma
Mabwell
Lycia Therapeutics, Inc
Thrive Earlier Detection
Triumvira Immunologics
Aro Biotherapeutics
Vortech Biosystems
Immusoft
Puma Biotechnology
Alexa global traffic share
Twitter followers
Overview
Funding
1
Add info
Add round
04 Apr
2017
$18,400,000
Venture capital (Series B)
Wicklow Capital
,
Latterell Venture Partners
,
Forward Ventures
,
+1
Viracta nabs $18.4M, Soon-Shiong as vice chair in Series B
FierceBiotech
